Similar DNA changes found in cells of both smokers and e-cigarette users19 March 2024E-cigarette users with a limited smoking history experience similar DNA changes to specific cheek cells as smokers, finds a new study led by researchers at UCL and University of Innsbruck, and other partners including University of Bristol.
Anti-diabetic drugs could lower risk of primary and secondary brain cancer22 February 2024Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.
Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins30 January 2024A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study, published in eBioMedicine, is the first to show that weight loss in people recently diagnosed with diabetes can change the levels of cancer-related chemicals circulating in the blood.
Professor Richard Martin interviewed by PLOS blog15 March 2023To mark this year's World Cancer Day, ICEP's Professor Richard Martin discussed the programme's aims, recent highlights, and the role of open access in supporting cancer research.
Roundtable brings cancer research to the Bristol public8 February 2023‘What do you think is most important for our health – our genetics or the environment we live in; nature or nurture?’ - This question and more were discussed in a recent public engagement roundtable.